Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An announcement from Imugene ( (AU:IMU) ) is now available.
Imugene Limited has announced the issuance of 5,501,568 quoted options, set to expire on March 30, 2026, at an exercise price of $0.43. These options have been allocated to participants of the Share Purchase Plan (SPP), reflecting the company’s strategic efforts to enhance its financial position and support its ongoing projects in the biotechnology sector.
The most recent analyst rating on (AU:IMU) stock is a Sell with a A$0.50 price target. To see the full list of analyst forecasts on Imugene stock, see the AU:IMU Stock Forecast page.
More about Imugene
Imugene Limited operates in the biotechnology industry, focusing on the development of immuno-oncology therapies. The company is engaged in creating innovative cancer treatments that harness the immune system to target and eradicate tumors.
Average Trading Volume: 1,750,636
Technical Sentiment Signal: Sell
Current Market Cap: A$82.22M
For detailed information about IMU stock, go to TipRanks’ Stock Analysis page.